| Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today's treat-to-target era | |
| Zhang Li; Tai Yu-Tzu; Ho Matthew Zhi Guang; Qiu Lugui; Anderson Kenneth C | |
| 2017 | |
| 卷号 | 6页码:20 |
| 关键词 | Bone marrow microenvironment CD20 CD38 Interferon-alpha Lymphoma Multiple myeloma Targeted therapy |
| ISSN号 | 2162-3619 |
| DOI | 10.1186/s40164-017-0081-6 |
| URL标识 | 查看原文 |
| 收录类别 | PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6361698 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Zhang Li,Tai Yu-Tzu,Ho Matthew Zhi Guang,et al. Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today's treat-to-target era[J],2017,6:20. |
| APA | Zhang Li,Tai Yu-Tzu,Ho Matthew Zhi Guang,Qiu Lugui,&Anderson Kenneth C.(2017).Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today's treat-to-target era.,6,20. |
| MLA | Zhang Li,et al."Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today's treat-to-target era".6(2017):20. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论